Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 4 de 4
Filtrar
Más filtros











Base de datos
Intervalo de año de publicación
1.
Spectrochim Acta A Mol Biomol Spectrosc ; 321: 124688, 2024 Nov 15.
Artículo en Inglés | MEDLINE | ID: mdl-38941754

RESUMEN

The sesquiterpene α-farnesene and its corresponding oxidation products, namely conjugated trienols (CTols) is well known to be correlated with the development of superficial scald, a typical physiological disorder after a long term of cold storage in pear fruit. In this work, hyperspectral imaging (HSI) technology was used for nondestructive predicting of α-farnesene and CTols [CT258, CT281 and CT(281-290)] content in 'Yali' pear. In order to obtain the best performance of calibration model and simplify the calibration model further, various preprocessing methods together with their combinations and different wavelength selection algorithms, including successive projections algorithm (SPA), competitive adaptive reweighted sampling (CARS) and uninformative variable elimination (UVE), were investigated and compared based on linear partial least square regression (PLSR) and nonlinear least square support vector machine (LS-SVM) models, respectively. In conclusion, compared to the PLSR models, the results of LS-SVM models based on original and preprocessing methods performed better for the prediction of α-farnesene and CTols, while the performance of LS-SVM models based on the selected characteristic wavelengths were worse. For α-farnesene, the best result was obtained by LS-SVM model based on MSC-FD pretreatment with the RPD value of 2.6, Rp = 0.925 and RMSEP = 4.387 nmol cm-2. And for CTols, CT281 performed better compared with CT258 and CT(281-290), achieving the result with RPD = 2.4, Rp = 0.913 and RMSEP = 2.734 nmol cm-2 based on LS-SVM model combined with SD pretreatment. The overall results illustrated HSI technology could be used for rapid and nondestructive prediction of α-farnesene and CTols in 'Yali' pear, which would be helpful for supporting postharvest decision systems.


Asunto(s)
Pyrus , Sesquiterpenos , Máquina de Vectores de Soporte , Pyrus/química , Sesquiterpenos/análisis , Sesquiterpenos/química , Análisis de los Mínimos Cuadrados , Imágenes Hiperespectrales/métodos , Algoritmos , Frutas/química , Calibración
2.
J Surg Res ; 174(2): e75-83, 2012 May 15.
Artículo en Inglés | MEDLINE | ID: mdl-22261596

RESUMEN

BACKGROUND: The 100% oxygen inhalation has been demonstrated to have a protective effect on mice with zymosan-induced generalized inflammation. However, the underlying mechanism is largely unknown. The present study was designed to explore the role of the cholinergic anti-inflammatory pathway in this animal model. METHODS: Oxygen inhalation was given to mice at 4 and 12 h after zymosan injection. One group of mice underwent vagotomy 7 d before zymosan injection. The other two groups of mice either received nicotinic acetylcholine receptor (nAChR) antagonist mecamylamine, or α7 nicotinic acetylcholine receptor (α7nAChR) antagonist methyllycaconitine 30 min before oxygen was given. RESULTS: The 100% oxygen treatment significantly decreased the serum level of TNF-α and increased the serum level of IL-10. The pathologic changes of the heart, lung, liver, and kidney were attenuated, as well as the dysfunction of liver and kidney. The 7-d survival rate of zymosan-challenged mice was also improved. Conversely, all these protective effects caused by pure oxygen treatment were abolished in those animals that received anti-cholinergic treatments. CONCLUSIONS: The cholinergic anti-inflammatory pathway may be involved in the 100% oxygen protective mechanism against zymosan-induced generalized inflammation in mice.


Asunto(s)
Antagonistas Nicotínicos , Oxígeno/uso terapéutico , Receptores Nicotínicos/fisiología , Síndrome de Respuesta Inflamatoria Sistémica/terapia , Vagotomía , Aconitina/análogos & derivados , Animales , Citocinas/sangre , Riñón/patología , Pruebas de Función Renal , Hígado/patología , Pruebas de Función Hepática , Pulmón/patología , Masculino , Mecamilamina , Ratones , Ratones Endogámicos ICR , Miocardio/patología , Insuficiencia Respiratoria/prevención & control , Zimosan
3.
Shock ; 36(3): 272-8, 2011 Sep.
Artículo en Inglés | MEDLINE | ID: mdl-21617579

RESUMEN

We have demonstrated that 100% oxygen inhalation is beneficial to zymosan-induced generalized inflammation, and reactive oxygen species may be involved in the protection of oxygen treatment. Other investigators suggest that reactive oxygen species may modulate the sympathetic nervous system activity and ß2-adrenergic receptor (ß2AR)-mediated pathway. Moreover, studies have demonstrated that ß2AR agonists are beneficial to sepsis. Therefore, we assessed the effects of ß2AR antagonist butoxamine on the protection of oxygen treatment against zymosan-induced generalized inflammation in mice. Mice were given oxygen treatment by exposure to 100% oxygen for 3 h starting at 4 and 12 h after zymosan injection, respectively. In the mortality study, survival was monitored for 7 days after zymosan injection in mice. At 24 h after zymosan injection, mice were killed, and blood sample and organs were harvested for analysis. We observed that 100% oxygen treatment prevented the abnormal changes in organ histopathology, lactate dehydrogenase and C-reactive protein in serum, inflammatory cytokines in serum and tissue, and arterial blood gas analysis and improved the survival rate in zymosan-challenged mice. We found that pretreatment with ß2AR antagonist butoxamine partly abolished the protection of 100% oxygen inhalation. We also showed that zymosan induced the increase in serum 3'-5'-cyclic adenosine monophosphate (cAMP) and the decrease in tissue cAMP. However, oxygen treatment increased the cAMP levels in both serum and tissue, which were partly abolished by pretreatment with butoxamine. Thus, 100% oxygen inhalation may protect against zymosan-induced generalized inflammation in mice partly through activation of ß2AR pathway and subsequently enhance cAMP levels in both serum and tissue.


Asunto(s)
Antagonistas de Receptores Adrenérgicos beta 2/farmacología , Butoxamina/farmacología , Inflamación/inducido químicamente , Inflamación/tratamiento farmacológico , Oxígeno/uso terapéutico , Receptores Adrenérgicos beta 2/metabolismo , Zimosan/toxicidad , Administración por Inhalación , Animales , AMP Cíclico/sangre , AMP Cíclico/metabolismo , Inflamación/metabolismo , Inflamación/prevención & control , Ratones , Oxígeno/sangre , Especies Reactivas de Oxígeno/metabolismo
4.
Shock ; 34(5): 495-501, 2010 Nov.
Artículo en Inglés | MEDLINE | ID: mdl-20351628

RESUMEN

Sepsis/multiple organ dysfunction syndrome is the leading cause of death in critically ill patients. Recently, it has been suggested that hydrogen gas (H2) exerts a therapeutic antioxidant activity by selectively reducing hydroxyl radical (•OH, the most cytotoxic reactive oxygen species). We have found that H2 inhalation significantly improved the survival rate and organ damage of septic mice with moderate or severe cecal ligation and puncture. In the present study, we investigated the effects of 2% H2 treatment on survival rate and organ damage in zymosan (ZY)-induced generalized inflammation model. Here, we found that 2% H2 inhalation for 60 min starting at 1 and 6 h after ZY injection, respectively, significantly improved the 14-day survival rate of ZY-challenged mice from 10% to 70%. Furthermore, ZY-challenged mice showed significant multiple organ damage characterized by the increase in serum biochemical parameters (aspartate aminotransferase, alanine aminotransferase, blood urea nitrogen, and creatinine), as well as lung, liver, and kidney histopathological scores at 24 h after ZY injection, which was significantly attenuated by 2% H2 treatment. In addition, we found that the beneficial effects of H2 treatment on ZY-induced organ damage were associated with the decreased levels of oxidative product, increased activities of antioxidant enzyme, and reduced levels of early and late proinflammatory cytokines in serum and tissues. In conclusion, this study provides evidence that H2 treatment protects against multiple organ damages in ZY-induced generalized inflammation model, suggesting the potential use of H2 as a therapeutic agent in the therapy of conditions associated with inflammation-related multiple organ dysfunction syndrome.


Asunto(s)
Antioxidantes/uso terapéutico , Hidrógeno/uso terapéutico , Inflamación/tratamiento farmacológico , Administración por Inhalación , Animales , Antioxidantes/administración & dosificación , Biomarcadores , Citocinas/análisis , Dinoprost/análogos & derivados , Dinoprost/análisis , Evaluación Preclínica de Medicamentos , Gases , Proteína HMGB1/análisis , Hidrógeno/administración & dosificación , Inflamación/inducido químicamente , Inflamación/complicaciones , Inflamación/metabolismo , Inflamación/patología , Masculino , Ratones , Ratones Endogámicos ICR , Insuficiencia Multiorgánica/etiología , Insuficiencia Multiorgánica/prevención & control , Oxidación-Reducción , Superóxido Dismutasa/análisis , Vísceras/patología , Zimosan/toxicidad
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA